v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTEREST AND EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Total Thermo Fisher Scientific Inc. Shareholders’ Equity
Common Stock
Capital in Excess of Par Value
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income/(Loss)
Noncontrolling Interests
Beginning balance at Dec. 31, 2024 $ 120              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 13              
Other comprehensive income/(loss) 5              
Contributions from (distributions to) noncontrolling interests (8)              
Ending balance at Sep. 27, 2025 129              
Common stock, beginning balance (in shares) at Dec. 31, 2024     444,000,000          
Beginning balance at Dec. 31, 2024 49,551 $ 49,584 $ 444 $ 17,962 $ 53,102 $ (19,226) $ (2,697) $ (33)
Treasury stock beginning balance (in shares) at Dec. 31, 2024           63,000,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under stock plans (in shares)     1,000,000          
Issuance of shares under stock plans 85 85 $ 1 142   $ (58)    
Stock-based compensation 226 226   226        
Purchases of company common stock (in shares)           6,000,000    
Purchases of company common stock (3,000) (3,000)       $ (3,000)    
Dividends declared (488) (488)     (488)      
Net income/(loss) 4,738 4,740     4,740     (1)
Other comprehensive income/(loss) (103) (103)         (103)  
Contributions from (distributions to) noncontrolling interests (2)             (2)
Excise tax from stock repurchases (26) (26)       (26)    
Disposition 42             42
Common stock, ending balance (in shares) at Sep. 27, 2025     445,000,000          
Ending balance at Sep. 27, 2025 51,024 51,018 $ 445 18,330 57,354 $ (22,310) (2,801) 7
Treasury stock ending balance (in shares) at Sep. 27, 2025           69,000,000    
Beginning balance at Jun. 28, 2025 126              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 5              
Other comprehensive income/(loss) (1)              
Ending balance at Sep. 27, 2025 129              
Common stock, beginning balance (in shares) at Jun. 28, 2025     444,000,000          
Beginning balance at Jun. 28, 2025 50,476 50,512 $ 444 18,232 55,901 $ (21,269) (2,797) (35)
Treasury stock beginning balance (in shares) at Jun. 28, 2025           67,000,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under stock plans (5) (5)   28   $ (32)    
Stock-based compensation 70 70   70        
Purchases of company common stock (in shares)           2,000,000    
Purchases of company common stock (1,000) (1,000)       $ (1,000)    
Dividends declared (163) (163)     (163)      
Net income/(loss) 1,616 1,616     1,616     1
Other comprehensive income/(loss) (4) (4)         (4)  
Contributions from (distributions to) noncontrolling interests (1)             (1)
Excise tax from stock repurchases (9) (9)       (9)    
Disposition 42             42
Common stock, ending balance (in shares) at Sep. 27, 2025     445,000,000          
Ending balance at Sep. 27, 2025 51,024 51,018 $ 445 18,330 57,354 $ (22,310) (2,801) 7
Treasury stock ending balance (in shares) at Sep. 27, 2025           69,000,000    
Beginning balance at Dec. 31, 2025 122              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 14              
Other comprehensive income/(loss) (1)              
Contributions from (distributions to) noncontrolling interests (7)              
Ending balance at Sep. 26, 2026 128              
Common stock, beginning balance (in shares) at Dec. 31, 2025     445,000,000          
Beginning balance at Dec. 31, 2025 $ 53,415 53,407 $ 445 18,563 59,156 $ (22,309) (2,448) 7
Treasury stock beginning balance (in shares) at Dec. 31, 2025 68,938,831         69,000,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under stock plans (in shares)     1,000,000          
Issuance of shares under stock plans $ 358 358 $ 1 424   $ (67)    
Stock-based compensation 261 261   261        
Purchases of company common stock (in shares)           7,000,000    
Purchases of company common stock (4,000) (4,000)       $ (4,000)    
Dividends declared (524) (524)     (524)      
Net income/(loss) 5,110 5,108     5,108     1
Other comprehensive income/(loss) 184 184         184  
Contributions from (distributions to) noncontrolling interests (2)             (2)
Excise tax from stock repurchases (33) (33)       (33)    
Common stock, ending balance (in shares) at Sep. 26, 2026     447,000,000          
Ending balance at Sep. 26, 2026 $ 54,767 54,761 $ 447 19,247 63,740 $ (26,408) (2,264) 6
Treasury stock ending balance (in shares) at Sep. 26, 2026 75,995,868         76,000,000    
Beginning balance at Jun. 27, 2026 $ 121              
Redeemable Noncontrolling Interest [Roll Forward]                
Net income/(loss) 5              
Other comprehensive income/(loss) 1              
Contributions from (distributions to) noncontrolling interests 0              
Ending balance at Sep. 26, 2026 128              
Common stock, beginning balance (in shares) at Jun. 27, 2026     446,000,000          
Beginning balance at Jun. 27, 2026 52,686 52,679 $ 446 18,870 62,194 $ (26,370) (2,460) 7
Treasury stock beginning balance (in shares) at Jun. 27, 2026           76,000,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of shares under stock plans (in shares)     1,000,000     0    
Issuance of shares under stock plans 240 240 $ 1 282   $ (43)    
Stock-based compensation 95 95   95        
Dividends declared (174) (174)     (174)      
Net income/(loss) 1,722 1,721     1,721      
Other comprehensive income/(loss) 196 196         196  
Contributions from (distributions to) noncontrolling interests (1)             (1)
Excise tax from stock repurchases 5 5       5    
Common stock, ending balance (in shares) at Sep. 26, 2026     447,000,000          
Ending balance at Sep. 26, 2026 $ 54,767 $ 54,761 $ 447 $ 19,247 $ 63,740 $ (26,408) $ (2,264) $ 6
Treasury stock ending balance (in shares) at Sep. 26, 2026 75,995,868         76,000,000